MAPK14 anticorps (Tyr322)
Aperçu rapide pour MAPK14 anticorps (Tyr322) (ABIN2306355)
Antigène
Voir toutes MAPK14 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Tyr322
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- MAP Kinase 14 (Tyr322) (Mitogen-activated Protein Kinase 14, MAPK 14, MAPK14, Mitogen-activated Protein Kinase p38alpha, MAP Kinase p38alpha, Cytokine Suppressive Anti-inflammatory Drug binding Protein, CSAID Binding Protein, CSBP, MAX-interacting Protein 2, MAP Kinase MXI2, SAPK2A)
-
Purification
- Purified by immunoaffinity chromatography.
-
Immunogène
- Synthetic non-phosphopeptide corresponding to amino acid residues surrounding Y322 of human MAPK14 (KLH).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- MAPK14 (Mitogen-Activated Protein Kinase 14 (MAPK14))
-
Autre désignation
- MAP Kinase 14
-
NCBI Accession
- NP_620581
-
UniProt
- Q16539
-
Pathways
- Signalisation MAPK, Neurotrophin Signaling Pathway, Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Regulation of Muscle Cell Differentiation, Regulation of Cell Size, Hepatitis C, Toll-Like Receptors Cascades, Autophagy, Thromboxane A2 Receptor Signaling, BCR Signaling, S100 Proteins
Antigène
-